Photographer: Brand X Pictures/Getty Images

Cancer Drug Once Bought for $7 Million May Now Fetch $18 Billion

Updated on

An overlooked drug bought by a biotech company for a mere $6.6 million a decade ago could become one of the biggest selling cancer treatments ever.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.